ECM
AMED

ETrade Capital Management’s Amedisys AMED Stock Holding History

ETrade Capital Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$1.43M Sell
6,049
-1,106
-15% -$251K 0.03% 282
2020
Q2 		$1.42M Sell
7,155
-1,248
-15% -$233K 0.03% 266
2020
Q1 		$1.54M Buy
8,403
+266
+3% +$47.3K 0.04% 225
2019
Q4 		$1.36M Buy
8,137
+2,752
+51% +$409K 0.03% 289
2019
Q3 		$705K Buy
5,385
+335
+7% +$43.6K 0.02% 451
2019
Q2 		$613K Sell
5,050
-2,051
-29% -$243K 0.02% 493
2019
Q1 		$875K Buy
7,101
+282
+4% +$35.4K 0.03% 362
2018
Q4 		$799K Buy
6,819
+148
+2% +$17.4K 0.03% 363
2018
Q3 		$834K Buy
6,671
+259
+4% +$28.6K 0.02% 413
2018
Q2 		$548K Buy
6,412
+394
+7% +$28.9K 0.02% 510
2018
Q1 		$363K Sell
6,018
-912
-13% -$51.9K 0.01% 581
2017
Q4 		$365K Buy
6,930
+227
+3% +$12K 0.01% 570
2017
Q3 		$375K Buy
6,703
+294
+5% +$15.5K 0.01% 540
2017
Q2 		$403K Buy
6,409
+285
+5% +$16.6K 0.02% 499
2017
Q1 		$313K Buy
+6,124
New +$292K 0.01% 515

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

ETrade Capital Management's AMED Position: Q3 2020 in Review

ETrade Capital Management reduced its Amedisys (AMED) stake by 15% in Q3 2020, selling an estimated $251K and leaving 6,049 shares worth $1.43M. The position accounts for 0.03% of the portfolio, ranked #282.

ETrade Capital Management first reported a position in AMED in Q1 2017 and has held it in 15 quarters since. The position peaked at $1.54M in Q1 2020. 398 funds tracked by Wall St. Rank hold AMED as of Q3 2020.

  • ETrade Capital Management held 6,049 shares of Amedisys worth $1.43M as of Q3 2020.
  • ETrade Capital Management sold 1,106 Amedisys shares in Q3 2020, an estimated $251K.
  • Amedisys made up 0.03% of ETrade Capital Management's portfolio in Q3 2020, its #282 holding.
  • ETrade Capital Management first reported a position in Amedisys in Q1 2017 and has held it in 15 quarters since.
  • ETrade Capital Management's Amedisys position peaked at $1.54M in Q1 2020.
  • 398 funds tracked by Wall St. Rank held Amedisys as of Q3 2020.

Based on ETrade Capital Management's 13F filing for Q3 2020, filed 13 Nov 2020.